Royal Bank of Canada
SRTA

Royal Bank of Canada’s Strata Critical Medical Inc SRTA Stock Holding History

Royal Bank of Canada’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Sell
1,742
-4,669
-73% -$22.5K ﹤0.01% 6299
2025
Q4 		$30K Sell
6,411
-1,993
-24% -$9.64K ﹤0.01% 5822
2025
Q3 		$42K Sell
8,404
-2,620
-24% -$11.6K ﹤0.01% 5894
2025
Q2 		$45K Buy
11,024
+7,253
+192% +$23.6K ﹤0.01% 5968
2025
Q1 		$10K Sell
3,771
-6,206
-62% -$22.3K ﹤0.01% 6140
2024
Q4 		$42K Sell
9,977
-4,096
-29% -$15.6K ﹤0.01% 5772
2024
Q3 		$42K Sell
14,073
-12,828
-48% -$40.8K ﹤0.01% 5781
2024
Q2 		$94K Buy
26,901
+3,972
+17% +$13.2K ﹤0.01% 5305
2024
Q1 		$66K Sell
22,929
-20,890
-48% -$64.5K ﹤0.01% 5407
2023
Q4 		$154K Buy
43,819
+13,240
+43% +$38K ﹤0.01% 5306
2023
Q3 		$79K Buy
30,579
+874
+3% +$3.07K ﹤0.01% 5531
2023
Q2 		$117K Buy
29,705
+2,929
+11% +$9.29K ﹤0.01% 5201
2023
Q1 		$91K Sell
26,776
-2,101
-7% -$8.57K ﹤0.01% 5249
2022
Q4 		$103K Buy
28,877
+5,343
+23% +$22.8K ﹤0.01% 5418
2022
Q3 		$95K Buy
23,534
+368
+2% +$1.89K ﹤0.01% 5339
2022
Q2 		$103K Sell
23,166
-413
-2% -$2.98K ﹤0.01% 5313
2022
Q1 		$200K Buy
23,579
+553
+2% +$3.89K ﹤0.01% 5084
2021
Q4 		$203K Sell
23,026
-2,152
-9% -$20.5K ﹤0.01% 5318
2021
Q3 		$262K Buy
25,178
+5,007
+25% +$43.7K ﹤0.01% 4923
2021
Q2 		$212K Buy
20,171
+14,037
+229% +$139K ﹤0.01% 5027
2021
Q1 		$63K Buy
6,134
+3,070
+100% +$42.7K ﹤0.01% 5743
2020
Q4 		$34K Buy
+3,064
New +$31.3K ﹤0.01% 5814
2020
Q3 		– Sell
-1,448
Closed -$14K – 6620
2020
Q2 		$14K Buy
+1,448
New +$14.2K ﹤0.01% 5710

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's SRTA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Strata Critical Medical Inc (SRTA) stake by 73% in Q1 2026, selling an estimated $22.5K and leaving 1,742 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #6299.

Royal Bank of Canada first reported a position in SRTA in Q2 2020 and has held it in 23 quarters since. The position peaked at $262K in Q3 2021. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Royal Bank of Canada held 1,742 shares of Strata Critical Medical Inc worth $7K as of Q1 2026.
  • Royal Bank of Canada sold 4,669 Strata Critical Medical Inc shares in Q1 2026, an estimated $22.5K.
  • Strata Critical Medical Inc made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6299 holding.
  • Royal Bank of Canada first reported a position in Strata Critical Medical Inc in Q2 2020 and has held it in 23 quarters since.
  • Royal Bank of Canada's Strata Critical Medical Inc position peaked at $262K in Q3 2021.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.